ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,246.95
0.18%
Dow Jones
38,807.33
0.25%
Gold vs US Dollar
2,360.765
0.24%
Brent Oil
78.605
0.06%
Bitcoin
71,108.00
0.04%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Revolution Medicines Inc (RVMD) Share Price

RVMD Revolution Medicines Inc

40.68
0.90 (2.26%)
06 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Revolution Medicines Inc NASDAQ:RVMD NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.90 2.26 40.68 36.90 42.00 41.05 39.19 39.92 1,015,175 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Biological Pds,ex Diagnstics 11.58M -436.37M -2.6496 -0.06 24.7M
 Type  Size  Price  Time  Units 
 9 10 41.09 23:49:54 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore RVMD News
05/06/202421:05GLOBERevolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
08/05/202421:02GLOBERevolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress
01/05/202421:05GLOBERevolution Medicines to Report Financial Results for First Quarter 2024 After Market Close on May 8, 2024
09/04/202420:34GLOBERevolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins
08/04/202416:36GLOBERevolution Medicines Announces Publications on the Discovery and Preclinical Profile of Representative of a New Class of RAS(ON) Multi-Selective Inhibitors Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins
04/04/202421:05GLOBERevolution Medicines to Participate in Upcoming Investor Conferences
28/03/202420:05GLOBERevolution Medicines to Deliver Multiple Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2024
Period
Draw mode
Data Downloads for RVMD

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Revolution Medicines Inc Articles